Compile Data Set for Download or QSAR
maximum 50k data
Found 42 Enz. Inhib. hit(s) with all data for entry = 5980
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103448(US8552037, 95)
Affinity DataIC50:  0.0220nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103446(US8552037, 93)
Affinity DataIC50:  0.0300nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103450(US8552037, 98)
Affinity DataIC50:  0.0380nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103446(US8552037, 93)
Affinity DataIC50:  0.0490nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103443(US8552037, 90)
Affinity DataIC50:  0.0570nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103437(US8552037, 82)
Affinity DataIC50:  0.0680nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103439(US8552037, 84)
Affinity DataIC50:  0.0790nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103448(US8552037, 95)
Affinity DataIC50:  0.0910nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103456(US8552037, 123)
Affinity DataIC50:  0.0950nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103450(US8552037, 98)
Affinity DataIC50:  0.120nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103445(US8552037, 92)
Affinity DataIC50:  0.130nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103443(US8552037, 90)
Affinity DataIC50:  0.130nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103456(US8552037, 123)
Affinity DataIC50:  0.140nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103442(US8552037, 89)
Affinity DataIC50:  0.150nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103449(US8552037, 97)
Affinity DataIC50:  0.150nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103440(US8552037, 86)
Affinity DataIC50:  0.190nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103440(US8552037, 86)
Affinity DataIC50:  0.220nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103438(US8552037, 83)
Affinity DataIC50:  0.220nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103437(US8552037, 82)
Affinity DataIC50:  0.240nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103455(US8552037, 121)
Affinity DataIC50:  0.25nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103438(US8552037, 83)
Affinity DataIC50:  0.25nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103445(US8552037, 92)
Affinity DataIC50:  0.280nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103454(US8552037, 116)
Affinity DataIC50:  0.280nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103449(US8552037, 97)
Affinity DataIC50:  0.280nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103441(US8552037, 87)
Affinity DataIC50:  0.310nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103442(US8552037, 89)
Affinity DataIC50:  0.310nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103436(US8552037, 81)
Affinity DataIC50:  0.330nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103452(US8552037, 100)
Affinity DataIC50:  0.360nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103436(US8552037, 81)
Affinity DataIC50:  0.370nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103452(US8552037, 100)
Affinity DataIC50:  0.410nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103439(US8552037, 84)
Affinity DataIC50:  0.430nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103454(US8552037, 116)
Affinity DataIC50:  0.540nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103453(US8552037, 107)
Affinity DataIC50:  0.660nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103453(US8552037, 107)
Affinity DataIC50:  0.75nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103455(US8552037, 121)
Affinity DataIC50:  0.770nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103441(US8552037, 87)
Affinity DataIC50:  0.880nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103447(US8552037, 94)
Affinity DataIC50:  6.20nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103451(US8552037, 99)
Affinity DataIC50:  8.5nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103444(US8552037, 91)
Affinity DataIC50:  9.60nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103447(US8552037, 94)
Affinity DataIC50:  11nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103444(US8552037, 91)
Affinity DataIC50:  15nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103451(US8552037, 99)
Affinity DataIC50:  19nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent